Cargando…

Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

INTRODUCTION: COVID-19 long-haulers, also decribed as having “long-COVID” or post-acute COVID-19 syndrome, represent 10% of COVID-19 patients and remain understudied. METHODS: In this prospective study, we recruited 30 consecutive patients seeking medical help for persistent symptoms (> 30 days)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scherlinger, Marc, Felten, Renaud, Gallais, Floriane, Nazon, Charlotte, Chatelus, Emmanuel, Pijnenburg, Luc, Mengin, Amaury, Gras, Adrien, Vidailhet, Pierre, Arnould-Michel, Rachel, Bibi-Triki, Sabrina, Carapito, Raphaël, Trouillet-Assant, Sophie, Perret, Magali, Belot, Alexandre, Bahram, Seiamak, Arnaud, Laurent, Gottenberg, Jacques-Eric, Fafi-Kremer, Samira, Sibilia, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270770/ https://www.ncbi.nlm.nih.gov/pubmed/34245450 http://dx.doi.org/10.1007/s40121-021-00484-w

Ejemplares similares

Effet de la vaccination anti-SARS-CoV-2 sur les symptômes prolongés post-Covid : résultat de l’enquête nationale VAXILONG
por: Scherlinger, M., et al.
Publicado: (2021)

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study
por: Scherlinger, Marc, et al.
Publicado: (2021)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

Évolution de l’immunité cellulaire et humorale anti-SARS-CoV-2 après 3 doses de vaccins chez des patients traités par rituximab
por: Felten, R., et al.
Publicado: (2021)

Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
por: Gallais, Floriane, et al.
Publicado: (2021)

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
por: François, Antoine, et al.
Publicado: (2013)

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France
por: Felten, Renaud, et al.
Publicado: (2021)

Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic
por: Scherlinger, Marc, et al.
Publicado: (2022)

Théorie de la discontinuité : un rôle de l’infection à SARS-CoV-2 dans le développement de l’auto-immunité ?
por: Scherlinger, M., et al.
Publicado: (2022)

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
por: Scherlinger, Marc, et al.
Publicado: (2023)

Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination
por: Martinot, Martin, et al.
Publicado: (2021)

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
por: Meyer, Alain, et al.
Publicado: (2016)

Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation
por: Carapito, Raphael, et al.
Publicado: (2017)

A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients
por: Mariotte, Alexandre, et al.
Publicado: (2020)

Difficulties and Psychological Impact of the SARS-CoV-2 Pandemic in Patients with Systemic Lupus Erythematosus: A Nationwide Patient Association Study
por: Scherlinger, Marc, et al.
Publicado: (2022)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis
por: Alsaleh, Ghada, et al.
Publicado: (2010)

Efficacy of an online cognitive behavioral therapy program developed for healthcare workers during the COVID-19 pandemic: the REduction of STress (REST) study protocol for a randomized controlled trial
por: Weiner, Luisa, et al.
Publicado: (2020)

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
por: Gallais, Floriane, et al.
Publicado: (2022)

Programme de thérapie cognitivo-comportementale (TCC) en ligne pour diminuer les effets du stress chez les professionnels de santé
por: Nourry, Nathalie, et al.
Publicado: (2022)

In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer
por: Schrambach, Stéphanie, et al.
Publicado: (2007)

MiR-30a-3p Negatively Regulates BAFF Synthesis in Systemic Sclerosis and Rheumatoid Arthritis Fibroblasts
por: Alsaleh, Ghada, et al.
Publicado: (2014)

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
por: Felten, Renaud, et al.
Publicado: (2022)

DICER1: A Key Player in Rheumatoid Arthritis, at the Crossroads of Cellular Stress, Innate Immunity, and Chronic Inflammation in Aging
por: De Cauwer, Aurore, et al.
Publicado: (2018)

An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides
por: Domingo-Calap, Pilar, et al.
Publicado: (2018)

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
por: Blaess, Julien, et al.
Publicado: (2020)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
por: Widawski, L., et al.
Publicado: (2022)

selectBoost: a general algorithm to enhance the performance of variable selection methods
por: Bertrand, Frédéric, et al.
Publicado: (2020)

Measuring the transcriptome-wide effects of aging on murine adipocytes using RNAseq
por: De Cauwer, Aurore, et al.
Publicado: (2023)

Type I IFN immunoprofiling in COVID-19 patients
por: Trouillet-Assant, Sophie, et al.
Publicado: (2020)

Long-term humoral response following Delta and Omicron BA.1 co-infection
por: Saade, Carla, et al.
Publicado: (2023)

Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients
por: Gallais, Floriane, et al.
Publicado: (2022)

How and why are rheumatologists relevant to COVID-19?
por: Felten, Renaud, et al.
Publicado: (2020)

Comment et pourquoi les rhumatologues sont importants face à la crise du COVID-19 ?()
por: Felten, Renaud, et al.
Publicado: (2020)

Retrieval practice improves memory in patients with schizophrenia: new perspectives for cognitive remediation
por: Jantzi, Camille, et al.
Publicado: (2019)

Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency
por: Carapito, Raphael, et al.
Publicado: (2018)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
por: Goncalves, David, et al.
Publicado: (2021)

Type‐I Interferon assessment in 45 minutes using the FilmArray(®) PCR platform in SARS‐CoV‐2 and other viral infections
por: Mommert, Marine, et al.
Publicado: (2021)

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
por: Su, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hpssri46smtm09edtrggvt42f6